SIMCERE PHARMA (02096) spent 10.1667 million Hong Kong dollars to repurchase 1.49 million shares on November 18th.
Sinopharm (02096) announced that on November 18, 2024, the company invested 1016.67 million...
SIMCERE PHARMA (02096) announced that on November 18, 2024, the company repurchased 1.49 million shares at a cost of 10.167 million Hong Kong dollars. The repurchase price was between 6.71 and 6.98 Hong Kong dollars per share.
Related Articles
BITFIRE GROUP (01611) Mid-term Performance: Impairment of cryptographic assets dragged down revenue, gross profit margin soared by 141.8%, and asset management scale doubled to HK$2.295 billion.
The new Le Diao L60 will be available for pre-sale release on May 29th, NIO's US stock closing surged more than 9%, and Hong Kong stocks opened with a strong increase of 10%.
Zscaler (ZS.US) hits record drop of over 30%: market fear of "AI disrupting software" outweighs performance.
BITFIRE GROUP (01611) Mid-term Performance: Impairment of cryptographic assets dragged down revenue, gross profit margin soared by 141.8%, and asset management scale doubled to HK$2.295 billion.
The new Le Diao L60 will be available for pre-sale release on May 29th, NIO's US stock closing surged more than 9%, and Hong Kong stocks opened with a strong increase of 10%.
Zscaler (ZS.US) hits record drop of over 30%: market fear of "AI disrupting software" outweighs performance.
